Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Major

Showing results (211-220 of 217) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 217 results.
Plos Pathogens|November 13, 2012
Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathyMolly R Perkins, Caroline Ryschkewitsch, Julia C Liebner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2016
Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the LiteratureChrista S Zerbe, Beatriz E Marciano, Rohit K Katial, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
NeuroAIDS, drug abuse, and inflammation: building collaborative research activitiesJoan W Berman, Monica J Carson, Linda Chang, et al.
Frontiers in Neurology|January 2, 2023
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapiesEli Hatchwell, Edward B Smith, Shapour Jalilzadeh, et al.
The Lancet. Neurology|July 24, 2021
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot studyIrene Cortese, Erin S Beck, Omar Al-Louzi, et al.
Blood|March 7, 2009
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectKenneth R Carson, Andrew M Evens, Elizabeth A Richey, et al.
The Lancet. Neurology|July 23, 2011
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringLudwig Kappos, David Bates, Gilles Edan, et al.
Pageof 22

Showing results (211-220 of 217) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
Plos Pathogens|November 13, 2012
Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathyMolly R Perkins, Caroline Ryschkewitsch, Julia C Liebner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2016
Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the LiteratureChrista S Zerbe, Beatriz E Marciano, Rohit K Katial, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
NeuroAIDS, drug abuse, and inflammation: building collaborative research activitiesJoan W Berman, Monica J Carson, Linda Chang, et al.
Frontiers in Neurology|January 2, 2023
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapiesEli Hatchwell, Edward B Smith, Shapour Jalilzadeh, et al.
The Lancet. Neurology|July 24, 2021
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot studyIrene Cortese, Erin S Beck, Omar Al-Louzi, et al.
Blood|March 7, 2009
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectKenneth R Carson, Andrew M Evens, Elizabeth A Richey, et al.
The Lancet. Neurology|July 23, 2011
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringLudwig Kappos, David Bates, Gilles Edan, et al.
Pageof 22